Podcasts about diabetes mellitus

Drs Carol H. Wysham and Christopher M. Kramer discuss heart failure and type 2 diabetes, and the role of incretin therapies in the management of HFpEF. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002048. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources The Incidence of Congestive Heart Failure in Type 2 Diabetes: An Update https://pubmed.ncbi.nlm.nih.gov/15277411/ Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease https://pubmed.ncbi.nlm.nih.gov/34601960/ Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update https://pubmed.ncbi.nlm.nih.gov/31167558/ Insulin Resistance and Hyperinsulinaemia in Diabetic Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/26678809/ Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024 https://pubmed.ncbi.nlm.nih.gov/38078592/ The Paradox of Low BNP Levels in Obesity https://pubmed.ncbi.nlm.nih.gov/21523383 Tirzepatide for Heart Failure With Preserved Ejection Fraction and Obesity https://pubmed.ncbi.nlm.nih.gov/39555826/ Cardiovascular Effects of Incretin-Based Therapies: Integrating Mechanisms With Cardiovascular Outcome Trials https://pubmed.ncbi.nlm.nih.gov/35050311/ Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF https://pubmed.ncbi.nlm.nih.gov/38294187/ Heart Failure With Preserved Ejection Fraction: Mechanisms and Treatment Strategies https://pubmed.ncbi.nlm.nih.gov/34379445/ Obesity and Heart Failure With Preserved Ejection Fraction: New Insights and Pathophysiological Targets https://pubmed.ncbi.nlm.nih.gov/35880317/ Epidemiology of Heart Failure in Diabetes: A Disease in Disguise https://pubmed.ncbi.nlm.nih.gov/38334818/ Semaglutide in Patients With Heart Failure With Preserved Ejection Fraction and Obesity https://pubmed.ncbi.nlm.nih.gov/37622681/ Mechanisms of Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/37674356/ Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/39225278/ Effects of Tirzepatide on Circulatory Overload and End-Organ Damage in Heart Failure With Preserved Ejection Fraction and Obesity: A Secondary Analysis of the SUMMIT Trial https://pubmed.ncbi.nlm.nih.gov/39551891/ Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, a Preserved Ejection Fraction, and Obesity https://pubmed.ncbi.nlm.nih.gov/39556714/ Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy https://pubmed.ncbi.nlm.nih.gov/39566869/6 Spironolactone for Heart Failure With Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/24716680/

A insulina semanal Icodec é uma nova promessa no tratamento do Diabetes Mellitus tipo 2, oferecendo mais comodidade com apenas uma aplicação por semana. Neste vídeo, abordamos as principais evidências científicas que embasam seu uso, incluindo eficácia, segurança e resultados dos estudos clínicos.Endocrinologia descomplicada para médicos e residentes.Aqui você encontra conteúdos sobre atualização médica, casos clínicos e preparação para provas de título.

Join endocrine experts Lubaina S. Presswala, DO, FACOI, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES; and Viral N. Shah, MD, FACE, as they explore the latest in continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems for managing diabetes. In this episode, they discuss the practical applications of diabetes technology, patient selection, shared decision-making, and considerations for device use in specific populations, including athletes and pregnant individuals. This conversation provides valuable insights to help clinicians navigate device options and enhance outcomes across diverse patient scenarios.

In this episode, guest host Liv Sosnoski looks at the essentials of Type 1 Diabetes Mellitus in the wilderness setting. From understanding the autoimmune nature of the disease to explaining how environmental factors like temperature, altitude, and exertion impact blood sugar control, Liv breaks it all down. She covers practical tips on insulin dosing, glucose monitoring, and what to pack before hitting the trail. This episode arms wilderness providers with the tools they need to support Type I diabetes adventurers confidently and safely.

Quais são as evidências de uso da insulina semanal Icodec em pacientes com Diabetes Mellitus tipo 1?

Seminare: https://henningwilts.de/seminare   Kontaktdaten: Henning Wilts: https://henningwilts.de info@henningwilts.de https://www.instagram.com/henningwilts/ https://www.facebook.com/henning.wilts/ www.youtube.com/@HenningWiltsTierarzt https://www.linkedin.com/in/henning-wilts-376a8722b/ https://www.tiktok.com/@henningwilts    

Physician Enterprise Grand Rounds session discussing best practices for Type 2 Diabetes Mellitus Management.Our speakers for the session are Mandeep Bajaj, MBBS, Vice Chair for Clinical Affairs and a Professor in the Department of Medicine at Baylor College of Medicine, and Avin P. Pothuloori, MD, Assistant Professor of Medicine at Creighton University School of Medicine.PanelistDebra Rockman, RN, MBA, System Vice President of Ambulatory Quality, CommonSpirit Health

Neste episódio resumimos as principais recomendações da recente atualização da diretriz de diagnóstico e rastreio de diabetes mellitus da Sociedade Brasileira de Diabetes.Referência:https://diretriz.diabetes.org.br/diagnostico-de-diabetes-mellitus/

Recomendações da ADA 2025 sobre manejo do diabetes mellitus no idoso

Qual é a relação entre o diabetes mellitus e a sarcopenia?

De enero a septiembre de 2024, en México las tres principales causas de muerte fueron: Enfermedades del corazón Diabetes mellitus Tumores malignos o cáncerSee omnystudio.com/listener for privacy information.

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction–associated steatotic liver disease in endocrine practice. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002045. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Type 2 Diabetes Mellitus https://emedicine.medscape.com/article/117853-overview Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review https://pubmed.ncbi.nlm.nih.gov/37700494/ Fibrosis-4 (FIB-4) Calculator https://www.hepatitisc.uw.edu/page/clinical-calculators/fib-4 Liver Fibrosis Assessment: MR and US Elastography https://pubmed.ncbi.nlm.nih.gov/34687329/ Using the FIB-4, Automatically Calculated, Followed by the ELF Test in Second Line to Screen Primary Care Patients for Liver Disease https://pubmed.ncbi.nlm.nih.gov/38806580/ American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD) https://pubmed.ncbi.nlm.nih.gov/35569886/ Mediterranean Diet and Nonalcoholic Fatty Liver Disease https://pubmed.ncbi.nlm.nih.gov/29785077/ Drug Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress and Direction https://pubmed.ncbi.nlm.nih.gov/39470028/ Current Status of Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Clinical Perspective https://pubmed.ncbi.nlm.nih.gov/39801787/ Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK576405/ Update on the Applications and Limitations of Alpha-Fetoprotein for Hepatocellular Carcinoma https://pubmed.ncbi.nlm.nih.gov/35110946/

Recomendações da ADA 2025 sobre rastreio e diagnóstico do diabetes mellitus em adultos

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on United States Pooled Cohort Cardiovascular Disease Risk Scores in Adults With Diabetes Mellitus.

Retrospectiva 2024: novo critério diagnóstico de diabetes mellitus

The pathophysiology of type I diabetes mellitus, the ATs role in the management of the athlete with type I diabetes mellitus, and educating athletes/stakeholders about type I diabetes mellitus Timestamps 3:51- What is diabetes mellitus? 6:10- Types of diabetes mellitus 9:39- The role of the AT in the management of the patient with type I diabetes mellitus 14:55- Diabetes mellitus and the pre-participation exam 20:36- Managing hypoglycemia/hyperglycemia 40:21- Educating patients/stakeholders on diabetes management-- ARTICLE CITATIONS used for this episode: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://atcornerds.wixsite.com/home/blog⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ AT CORNER FACEBOOK GROUP: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/groups/atcornerpodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram, Website, YouTube, and other links: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠atcornerds.wixsite.com/home/links⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ EMAIL US: atcornerds@gmail.com SAVE on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbridge⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: Use code ATCORNER to get $150 off your subscription Music: Jahzzar (betterwithmusic.com) CC BY-SA — TO GET CEUs, enroll in this course: https://clinicallypressed.org/courses-home/ Take the quiz and course evaluation and your certificate will be generated for you! We have no financial disclosures or conflict of interests. -- -Sandy & Randy

A obesidade, uma epidemia mundial em níveis crescentes, está associada a centenas de doenças e, dentre estas, a Diabetes Mellitus tipo 2. Maus hábitos alimentares, sedentarismo e o consumo de alimentos ricos em gorduras, açúcares e de produtos refinados associam-se ao desenvolvimento da obesidade e, em muitos casos, de diabetes. Esta doença tão importante e que, se negligenciada, pode ter desfechos trágicos. Para falar sobre o tema, o âncora Jota Batista conversa com o cirurigião bariátrico, João Câmara.

Warum bekommen Regierungen und die Staatengemeinschaft den Hunger auf der Welt nicht in den Griff? Zumindest einige Forschende sagen: Eine Welt ohne Hunger ist möglich. Aber wie könnte das gelingen? Autorin Sarah Emminghaus ist für ihre Recherche dorthin gereist, wo Menschen an Mangelernährung leiden - sie war in Madagaskar und hat mit den Menschen vor Ort gesprochen. Im Gespräch mit Host Lucie Kluth erzählt sie davon, was im Kampf gegen Hunger bereits getan wird, wie die Situation vom Klimawandel beeinflusst wird und wie die Kolonialzeit noch heute nachwirkt. HINTERGRUNDINFORMATIONEN 1. Alexander, P. et al. Losses, inefficiencies and waste in the global food system. Agricultural Systems. 2017; 153 (190-200). https://doi.org/10.1016/j.agsy.2017.01.014 2. Ritchie, H. Increasing agricultural productivity across Sub-Saharan Africa is one of the most important problems this century. Our World in Data. https://ourworldindata.org/africa-yields-problem [Aufgerufen am 28. Oktober 2024] 3. Weltbank. Demographic Transition : Lessons from Bangladesh's Success Story (English). https://documents.worldbank.org/en/publication/documents-reports/documentdetail/716001588089852253/demographic-transition-lessons-from-bangladeshs-success-story [Aufgerufen am 28. Oktober 2024] 4. FAO. Hunger and food insecurity. https://www.fao.org/hunger/en/ [Aufgerufen am 28. Oktober 2024] 5. Welthunger-Index. https://www.welthungerhilfe.de/fileadmin/pictures/publications/de/studies-analysis/2024-welthunger-index-whi-synopse.pdf [Aufgerufen am 28. Oktober 2024] 6. Adeboye, B. et al. Obesity and its health impact in Africa: a systematic review. Cardiovascular Journal of Africa. 2012 Oct;23(9):512–521. https://doi.org/10.5830/CVJA-2012-040 7. Danquah, I. et al. Type 2 Diabetes Mellitus and Increased Risk for Malaria Infection. Emerging infectious diseases. 2020; 16(10), 1601–1604. https://doi.org/10.3201/eid1610.100399 8. Carrillo-Larco, RM et al. Is diabetes associated with malaria and malaria severity? A systematic review of observational studies. Wellcome Open Research. 2019; 4(136). https://doi.org/10.12688/wellcomeopenres.15467.3 9. Restrepo BI et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bulletin of the World Health Organization. 2011;89(5):352–359. https://doi.org/10.2471/BLT.10.085738 10. Global Hunger Index vs. GDP per capita, 2000 to 2021. https://ourworldindata.org/grapher/global-hunger-index-vs-gdp-per-capita?time=2000..2021 [Aufgerufen am 28. Oktober 2024] 11. Child and maternal malnutrition death rates vs. GDP per capita, 1990 to 2021. https://ourworldindata.org/grapher/child-maternal-malnutrition-gdp?time=1990..2021 [Aufgerufen am 28. Oktober 2024]

Warum bekommen Regierungen und die Staatengemeinschaft den Hunger auf der Welt nicht in den Griff? Zumindest einige Forschende sagen: Eine Welt ohne Hunger ist möglich. Aber wie könnte das gelingen? Autorin Sarah Emminghaus ist für ihre Recherche dorthin gereist, wo Menschen an Mangelernährung leiden - sie war in Madagaskar und hat mit den Menschen vor Ort gesprochen. Im Gespräch mit Host Lucie Kluth erzählt sie davon, was im Kampf gegen Hunger bereits getan wird, wie die Situation vom Klimawandel beeinflusst wird und wie die Kolonialzeit noch heute nachwirkt. HINTERGRUNDINFORMATIONEN 1. Alexander, P. et al. Losses, inefficiencies and waste in the global food system. Agricultural Systems. 2017; 153 (190-200). https://doi.org/10.1016/j.agsy.2017.01.014 2. Ritchie, H. Increasing agricultural productivity across Sub-Saharan Africa is one of the most important problems this century. Our World in Data. https://ourworldindata.org/africa-yields-problem [Aufgerufen am 28. Oktober 2024] 3. Weltbank. Demographic Transition : Lessons from Bangladesh's Success Story (English). https://documents.worldbank.org/en/publication/documents-reports/documentdetail/716001588089852253/demographic-transition-lessons-from-bangladeshs-success-story [Aufgerufen am 28. Oktober 2024] 4. FAO. Hunger and food insecurity. https://www.fao.org/hunger/en/ [Aufgerufen am 28. Oktober 2024] 5. Welthunger-Index. https://www.welthungerhilfe.de/fileadmin/pictures/publications/de/studies-analysis/2024-welthunger-index-whi-synopse.pdf [Aufgerufen am 28. Oktober 2024] 6. Adeboye, B. et al. Obesity and its health impact in Africa: a systematic review. Cardiovascular Journal of Africa. 2012 Oct;23(9):512–521. https://doi.org/10.5830/CVJA-2012-040 7. Danquah, I. et al. Type 2 Diabetes Mellitus and Increased Risk for Malaria Infection. Emerging infectious diseases. 2020; 16(10), 1601–1604. https://doi.org/10.3201/eid1610.100399 8. Carrillo-Larco, RM et al. Is diabetes associated with malaria and malaria severity? A systematic review of observational studies. Wellcome Open Research. 2019; 4(136). https://doi.org/10.12688/wellcomeopenres.15467.3 9. Restrepo BI et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bulletin of the World Health Organization. 2011;89(5):352–359. https://doi.org/10.2471/BLT.10.085738 10. Global Hunger Index vs. GDP per capita, 2000 to 2021. https://ourworldindata.org/grapher/global-hunger-index-vs-gdp-per-capita?time=2000..2021 [Aufgerufen am 28. Oktober 2024] 11. Child and maternal malnutrition death rates vs. GDP per capita, 1990 to 2021. https://ourworldindata.org/grapher/child-maternal-malnutrition-gdp?time=1990..2021 [Aufgerufen am 28. Oktober 2024]

Nessa live, eu conversei com a Jamile Meidas (@meu_jeito_tipo1) sobre Diabetes tipo 1 e dieta carnívora. Aos 35 anos, Jamile Meidas recebeu seu diagnóstico de Diabetes Mellitus tipo 1 e deu uma nova direção em sua vida. Além de incluir exercícios físicos em sua rotina diária, também manteve uma dieta baixa em carboidratos para auxiliá-la no controle glicêmico. Porém, em 2023, abriu seu terceiro diagnóstico de doença autoimune. Com Hipotireoidismo de Hashimoto, DM1 e Doença Celíaca, precisou, mais uma vez, repensar suas ações. Iniciou mais uma graduação, Nutrição, para que pudesse compreender onde poderia melhorar e evitar outras doenças.  Em agosto deste ano, após algumas tentativas, com orientação de Henrique Autran, encarou o desafio de fazer a Dieta Carnívora. Além de emagrecer alguns quilos, seu objetivo principal era, e é, abrandar a atividade do seu sistema autoimune a partir da recuperação da sua função intestinal. Ajude a rebelião saudável! Seja um apoiador do nosso movimento e garanta que as informações transmitidas continuarão gratuitas para todos! Além de ajudar, você terá acesso a um post mensal exclusivo para apoiadores! Acesse https://apoia.se/rebeliaosaudavel e contribua com a quantia que puder! Ajude a manter esse conteúdo vivo! #facapartedarebeliao Estamos também no telegram com um grupo exclusivo que você pode participar. Lá no telegram eu consigo compartilhar materiais exclusivos que não dá para compartilhar no Instagram. Além disso, toda segunda feira às 18:00 temos a Reunião da Rebelião Saudável com a participação de Profissionais de Saúde. Na reunião discutimos assuntos relevantes a respeito de saúde e qualidade de vida. Você pode acessar o grupo no telegram em https://t.me/RebeliaoSaudavel. Se você gosta de nosso trabalho, se inscreva e divulgue nosso Canal. Essa atitude é muito importante para a Rebelião saudável e vai ajudar nosso movimento a chegar a cada vez mais pessoas. Você também pode nos acompanhar no instagram, http://www.instagram.com/henriqueautran.   E em nosso canal do YouTube: https://youtube.com/c/henriqueautran. 

Nessa live, eu conversei com a Jamile Meidas (@meu_jeito_tipo1) sobre Diabetes tipo 1 e dieta carnívora. Aos 35 anos, Jamile Meidas recebeu seu diagnóstico de Diabetes Mellitus tipo 1 e deu uma nova direção em sua vida. Além de incluir exercícios físicos em sua rotina diária, também manteve uma dieta baixa em carboidratos para auxiliá-la no controle glicêmico. Porém, em 2023, abriu seu terceiro diagnóstico de doença autoimune. Com Hipotireoidismo de Hashimoto, DM1 e Doença Celíaca, precisou, mais uma vez, repensar suas ações. Iniciou mais uma graduação, Nutrição, para que pudesse compreender onde poderia melhorar e evitar outras doenças.  Em agosto deste ano, após algumas tentativas, com orientação de Henrique Autran, encarou o desafio de fazer a Dieta Carnívora. Além de emagrecer alguns quilos, seu objetivo principal era, e é, abrandar a atividade do seu sistema autoimune a partir da recuperação da sua função intestinal. Ajude a rebelião saudável! Seja um apoiador do nosso movimento e garanta que as informações transmitidas continuarão gratuitas para todos! Além de ajudar, você terá acesso a um post mensal exclusivo para apoiadores! Acesse https://apoia.se/rebeliaosaudavel e contribua com a quantia que puder! Ajude a manter esse conteúdo vivo! #facapartedarebeliao Estamos também no telegram com um grupo exclusivo que você pode participar. Lá no telegram eu consigo compartilhar materiais exclusivos que não dá para compartilhar no Instagram. Além disso, toda segunda feira às 18:00 temos a Reunião da Rebelião Saudável com a participação de Profissionais de Saúde. Na reunião discutimos assuntos relevantes a respeito de saúde e qualidade de vida. Você pode acessar o grupo no telegram em https://t.me/RebeliaoSaudavel. Se você gosta de nosso trabalho, se inscreva e divulgue nosso Canal. Essa atitude é muito importante para a Rebelião saudável e vai ajudar nosso movimento a chegar a cada vez mais pessoas. Você também pode nos acompanhar no instagram, http://www.instagram.com/henriqueautran.   E em nosso canal do YouTube: https://youtube.com/c/henriqueautran. 

Marcela Belleza e Letícia Angoleri convidam Nathalie Santana para falar de um tema inédito no TdC: diabetes tipo 1! O episódio está dividido em 4 partes:1. Como fazer o diagnóstico? 2. Como insulinizar?3. Quais são as metas do tratamento?4. Como seguir?Referências:1. Silva Júnior WS, Gabbay M, Lamounier R, Bertoluci M. Insulinoterapia no diabetes mellitus tipo 1 (DM1). Diretriz Oficial da Sociedade Brasileira de Diabetes (2023). DOI: 10.29327/557753.2022-5, ISBN: 978-85-5722-906-8. 2. American Diabetes Association, novembro/23. https://diabetesjournals.org/care/issue/47/Supplement_13. https://steno.shinyapps.io/T1RiskEngine/ 4. Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD0032875. Siebenhofer, A et al. “Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.” The Cochrane database of systematic reviews ,2 CD003287. 19 Apr. 2006, doi:10.1002/14651858.CD003287.pub4

Wat zijn de belangrijkste wijzigingen in de herziene NHG-Standaard Diabetes mellitus type 2 (DM2)? Werkgroepleden Bas Houweling en Bertien Hart praten je in 40 minuten bij over onder meer een vernieuwd medicatieplan en DM2 in remissie. 

To have your question featured in a future video, please email: questions@drmdc.health

¿Han escuchado personas comentar que existe una diabetes mala y otra buena? Pues en este mes donde hacemos conciencia en temas de diabetes, queremos platicar qué es la diabetes tipo 1 y por qué mucha gente se asusta con este diagnóstico. Complementa esta información escuchando estos capítulos: T1 Cap 32 Diabetes ¿estás en riesgo? https://youtu.be/aFa-YPMToBg?si=jOcpyqMafdwKgzoZ T3 Cap 35 | Complicaciones de la Diabetes https://www.youtube.com/watch?v=zIvWGaXJlOw&t=1057s T1 Cap 38 Diabetes tipo 2 Tratamiento https://www.youtube.com/watch?v=SJ87E3g4GPk T3 Cap 37 | Insulinoterapia https://www.youtube.com/watch?v=-zWvmiSDyYg&t=475s T4 Cap 18 | Diabetes gestacional y alimentación https://www.youtube.com/watch?v=b5ctxbOeweQ&t=1621s T5 Cap 8 | Bebidas y Diabetes https://www.youtube.com/watch?v=z2j1IWqV2vU Búscanos en: Spotify - https://spoti.fi/2PLIXFV Apple podcast - https://apple.co/31XRnfT Google podcast - https://bit.ly/3fN4YPf Ivoox - https://bit.ly/2QbM1LT y en YouTube búscanos como NutriEat Contigo https://bit.ly/32dTtbI ¡suscríbete y activa la campanita para que te lleguen todas las notificaciones! Dudas, comentarios o sugerencias...¡Escríbenos! L.N Carla Paola AM ⚕ Envíame un WhatsApp 55 6325 6115. Búscame en Facebook, X e Instagram como @Nut.CarlaPaola #NutrieatContigo

Osteoporose und Zucker... Gibt es einen Zusammenhang zwischen Diabetes mellitus und Osteoporose? Und beeinflusst die Art des Diabetes mellitus und die Diabetesmedikamente das Knochenbruchrisiko? Spannende Fragen, denen wir in der aktuellen Folge gemeinsam mit Dr. Ulrich Deuß, Facharzt für Endokrinologie auf den Grund gehen möchten.

Eine erhöhte Wasseraufnahme und ein damit verbundener vermehrter Urinabsatz bei unseren vierbeinigen Lieblingen, kann oftmals viele Ursachen haben. Die richtige Diagnose ist oft auf Anhieb nicht zu stellen bzw. zu finden. In dieser Folge werden kurz und knapp speziell für die Tierhalterberatung durch die TFA, wertvolle Parameter und Tools zum Thema Polyurie und Polydipsie an die Hand gegeben.

Episode 179: Impact of intermittent fasting Impact on T2DMFuture Dr. Carlisle explains the physiology of fasting and how it can help revert type 2 diabetes. Dr. Arreaza adds details on how to do intermittent fasting. Written by Cameron Carlisle, MSIV, Ross University School of Medicine. Comments and edits by Hector Arreaza, MD, FAAFP.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.What is type 2 Diabetes Mellitus (T2DM)?-Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and impaired glucose regulation. -This impaired regulation can lead to hyperglycemia, contributing to complications in a myriad of organs: heart, kidneys, eyes, nerves, etc. (target organs). According to the CDC, more than 38 million Americans have T2DM (about 1/10 people). -Multiple mechanisms are believed to contribute to insulin resistance in obese patients with T2DM, such as increased lipid deposition throughout the body and systemic inflammation.What is Intermittent Fasting (IF)? Intermittent fasting (IF) has recently gained popularity as a dietary approach for health benefits, but it has been around for thousands of years. IF is an eating pattern that alternates between eating and fasting (no calories consumed) over a specific period of time. When you are fasting, you are allowed and encouraged to keep drinking water and non-caloric drinks, like coffee, tea, and even homemade bone broth.-According to the International Food Information Council Foundation (IFIC), 10% of Americans engage in IF daily. -According to Mark Mattson, a neuroscientist and IF expert for over 25 years, a mechanism called “metabolic switching” is seen with IF. This is when your body runs out of glucose and starts burning fat (i.e., fatty oxidation). These metabolic changes can help protect your organs and reduce the risk of chronic conditions, like T2DM. Common IF methods: Time-restricted eating: Most common method, involves eating within a specific time frame (e.g., the 16:8, 18:6, 12:12 method is also common.  [16:8 means you have 16 hours of fasting and 8 hours of eating.]Alternate-day fasting: Alternating between fasting days and normal eating days.  [Find more info in The Complete Guide to Fasting, by Jason Fung, who is a nephrologist, he explains that alternate-day is basically eating every other day, which would give 36 hours of fasting, but if you are a beginner you can try a 24 hours fasting, in short, not eating breakfast any day of the week and having lunch 4 days a week, and dinner every night.]5:2 diet (aka periodic fasting): Maintaining a normal diet for 5 days, with 2 days (usually non-consecutive) of caloric restriction (25% of normal caloric intake; e.g., 500 calorie meal). IF is strongly believed to improve metabolic health in individuals with T2DM by reducing insulin resistance via increasing insulin sensitivity, promoting weight loss (patients with obesity and DM… AKA patients with diabesity), and enhancing lipolysis via fat oxidation.While fasting, the body goes through several phases that affect how energy is metabolized. Between 0 and 4 hours after eating, the body enters a feeding state, using glucose as its main energy source. After fasting for 12-16 hours, the body enters ketosis and starts to use fat for energy. Within 24-36 hours, autophagy begins, a process that recycles damaged cells and allows for cellular repair. This process can have great benefits for people with T2DM, such as improved insulin sensitivity and glucose regulation. Pathophysiology of Implementing IF in T2DM. -IF is thought to increase insulin sensitivity by decreasing fatty tissue in the body (i.e., visceral adipose tissue), which is correlated to insulin resistance. Insulin resistance is defined as higher than normal circulating insulin levels needed for a glucose lower response, which is thought to be the culprit for the generation of T2DM. It means you need high levels of insulin to keep glucose normal. -Obesity is an important risk factor for T2DM. Visceral adipose tissue functions as an organ via the secretion of adipokines (cytokines or cellular messengers produced by adipose tissue): leptin and adiponectin. Leptin: proinflammatory, leading to chronic inflammation. Patients with higher BMI levels and increased insulin resistance were found to have increased leptin levels.[Leptin is a good hormone at normal levels, but there is leptin resistance] Adiponectin: anti-inflammatory and antidiabetic effects. Higher adiponectin levels result in decreased hepatic gluconeogenesis, enhanced glucose absorption, and enhanced skeletal muscle and hepatic fatty acid oxidation. Levels drop as visceral fat increases. -Dr. López-Jaramillo, a Colombian endocrinologist and researcher, and colleagues published a review in 2014 examining the imbalance in the levels of leptin and adiponectin in individuals with metabolic syndrome. This imbalance (increase in leptin and decrease in adiponectin) is linked to obesity and insulin resistance, which has been shown to increase the risk of T2DM. It has been shown that IF has resulted in the reduction of leptin levels and increased levels of adiponectin, which leads to decreased insulin resistance and increased insulin sensitivity. -IF allows pancreatic beta-cells to rest by not having to secrete insulin constantly. This allows the beta-cells of the pancreas to improve in function over time. In addition, IF has been shown to lead to noticeable weight loss and loss in body fat, both of which play an important contribution in managing T2DM. Research demonstrates that this weight loss increases insulin sensitivity and decreases the need for insulin therapy, making IF a powerful approach for improving metabolic health. AMP-Activated Protein Kinase (AMPK) and Its Role in IF and T2DM Recent research has highlighted an important enzyme seen in IF, AMP-activated protein kinase (AMPK), which plays a vital role as an important energy sensor in cells. It is activated when cellular energy levels are low, such as during IF. A 2020 research study in Nature Reviews Endocrinology explains that activation of AMPK aids in suppressing gluconeogenesis and stimulates fatty acid oxidation, leading to optimal energy balance and reduction of visceral adipose tissue accumulation, a major contributor to insulin resistance and T2DM progression. AMPK is upregulated during fasting, which enhances glucose metabolism and reduces insulin resistance. This is imperative in managing T2DM, as it counters the effects of insulin resistance associated with T2DM.Exercise, which also promotes AMPK activation, complements IF and can promote a synergistic effect in improving insulin sensitivity and promoting fat burning, New Research Findings on IF and T2DM -The EARLY (Exploration of Treatment of Newly Diagnosed Overweight/Obese Type 2 Diabetes Mellitus) study is a randomized clinical trial published in JAMA Network Open (2024). Findings In this randomized clinical trial study found that a time-restricted eating window significantly improved fasting glucose levels and HbA1c levels in individuals with T2DM. The study examined the effect of a 16-week 5:2 meal replacement (5:2 MR) fasting plan that consisted of five days of normal eating and 2 days, nonconsecutive of restricted diet (500-600 calories). This group was examined alongside a group of patients who took metformin 0.5 g BID and empagliflozin 10 mg QD. The study wanted to investigate the changes in HbA1c in Chinese adults with early T2DM.-The study was a randomized clinical trial of 405 adults, and a study showed that the 5:2 MR approach led to better glycemic control at 16 weeks compared to the counter treatments with metformin and empagliflozin. The 5:2 MR group had the greatest reduction in HbA1c (-1.9%), followed by metformin (-1.6%), and empagliflozin (-1.5%). The 5:2 MR plan also revealed the greatest weight loss (-9.7 kg), followed by empagliflozin (-5.8 kg), and metformin (-5.5 kg). -This research suggests IF, such as 5:2 MR, can be a powerful tool in the management of T2DM and improving metabolic health. This study can potentially open doors for healthcare providers to provide the 5:2 MR approach for individuals as an effective initial lifestyle intervention. However, follow-up studies are needed to assess the effectiveness and durability of the 5:2 MR.Safety and Risks of IF in T2DM. -IF when combined with glucose-lowering medications (e.g., insulin, sulfonylureas, GLP-1 agonists) can increase the risk of hypoglycemia. Also, prolonged fasting can lead to nutrient deficiencies if not planned carefully. Patients should be counseled on maintaining a balanced, nutritious diet during non-fasting days. -IF is not suitable for everyone. Children under the age of 18 should not try IF due to needing proper calories for adequate development and proper growth. Also, it is recommended that pregnant or breastfeeding women do not undergo IF. It is advised that people with eating disorders should not try IF. -Individuals with certain medical conditions, such as kidney stones or gastroesophageal disease should speak with their doctor before trying IF. Also, patients on insulin or other glucose-lowering medications should adjust their dose and talk with their healthcare providers to prevent hypoglycemia during fasting. It is recommended that each person speak with their doctor to discuss the safety and risks of IF and see if it would benefit the individual before starting IF. -Many studies have explored the benefits of IF at the micro level revealing its cellular benefits and on a macro level of the body as a whole. However, more research is needed to confirm the long-term effects of IF on glycemic control and its sustainability as a therapeutic approach for T2DM. Conclusion:-IF shows potential for improving glycemic control, promoting weight loss, and enhancing metabolic health in individuals with T2DM. Despite its benefits, IF may present with risks, such as hypoglycemia, nutrition deficiencies, or dehydration in certain patients. Therefore, it may not be suitable for all individuals. It's important to monitor patients who engage in IF, especially for patients with T2DM. Patients should follow up with their doctor for individualized IF plans in patients with T2DM. ______________This week we thank Hector Arreaza and Cameron Carlisle. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Albosta, Michael, and Jesse Bakke. “Intermittent Fasting: Is There a Role in the Treatment of Diabetes? A Review of the Literature and Guide for Primary Care Physicians - Clinical Diabetes and Endocrinology.” BioMed Central, BioMed Central, 3 Feb. 2021, doi.org/10.1186/s40842-020-00116-1.Blumberg, Jack, et al. “Intermittent Fasting: Consider the Risks of Disordered Eating for Your Patient - Clinical Diabetes and Endocrinology.” BioMed Central, BioMed Central, 21 Oct. 2023, https://clindiabetesendo.biomedcentral.com/articles/10.1186/s40842-023-00152-7.De Cabo, Rafael, and Mark P. Mattson. “Effects of intermittent fasting on health, aging, and disease.” New England Journal of Medicine, vol. 381, no. 26, 26 Dec. 2019, pp. 2541–2551, https://doi.org/10.1056/nejmra1905136.Guo, Lixin, et al. “A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes.” JAMA Network Open, vol. 7, no. 6, 21 June 2024, https://doi.org/10.1001/jamanetworkopen.2024.16786.Herz, Daniel, et al. “Efficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review.” Nutrients, U.S. National Library of Medicine, 10 Aug. 2023, www.ncbi.nlm.nih.gov/pmc/articles/PMC10459496/. Herzig, S., & Shaw, R. J. (2018). AMPK: Guardian of metabolism and mitochondrial homeostasis. Nature Reviews Molecular Cell Biology, 19(2), 121-135.Longo, V. D., & Mattson, M. P. (2014). Fasting: Molecular mechanisms and clinical applications. Cell Metabolism, 19(2), 181-192. https://doi.org/10.1016/j.cmet.2013.12.008López-Jaramillo P, Gómez-Arbeláez D, López-López J, et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Hormone Molecular Biology and Clinical Investigation. 2014;18(1):37–45.Mattson, Mark P., et al. “Impact of intermittent fasting on health and disease processes.” Ageing Research Reviews, vol. 39, Oct. 2017, pp. 46–58, https://doi.org/10.1016/j.arr.2016.10.005. Patikorn, Chanthawat, et al. “Intermittent fasting and obesity-related health outcomes.” JAMA Network Open, vol. 4, no. 12, 17 Dec. 2021, https://doi.org/10.1001/jamanetworkopen.2021.39558.Sharma, Suresh K, et al. “Effect of Intermittent Fasting on Glycaemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” TouchREVIEWS in Endocrinology, U.S. National Library of Medicine, May 2023, www.ncbi.nlm.nih.gov/pmc/articles/PMC10258621/#:~:text=In%20IF%2C%20eating%20habits%20are,the%20risk%20of%20developing%20T2DM.Xiaoyu, Wen, et al. “The effects of different intermittent fasting regimens in people with type 2 diabetes: A network meta-analysis.” Frontiers in Nutrition, vol. 11, 25 Jan. 2024, https://doi.org/10.3389/fnut.2024.1325894. Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Send us a textUnlock the future of feline health with our special guest, Dr. Ellen Behrend, as she unveils the transformative potential of SGLT2 inhibitors for cats navigating the challenges of diabetes mellitus. She focuses on velagliflozin, a once-daily liquid oral SGLT2 inhibitor and brings her passion for endocrinology to the forefront, sharing her insights into this groundbreaking treatment originally successful in human type 2 diabetes. Join us as we dive into this new era of easier diabetes management for your feline friends. In our engaging discussion, we venture into the evolving landscape of diabetes care in pets, spotlighting novel treatments and their unexpected benefits for renal and cardiac health in cats. Ellen's personal anecdotes underscore the value of critical thinking and mentorship within veterinary studies, while we demystify common misconceptions about SGLT2 inhibitors, particularly diabetic ketoacidosis risks. Don't miss Ellen's article in JAVMA and join us next week for more insightful conversations. Please remember to rate and review us on your favorite podcast platform!JAVMA open access article: https://doi.org/10.2460/javma.24.03.0174INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

In this episode, William Maclean, M.Sc. Chin. Med., explores the Traditional Chinese Medicine approach to treating Diabetes Mellitus. Discover how TCM focuses on balancing Spleen and Kidney function, addressing common complications like Qi and Yin deficiency, and supporting overall well-being. Tune in to gain insights into how Chinese medicine can be integrated into the treatment of this chronic condition.You can access the written article here.  Select your favorite podcast provider to subscribe and get notified of new recordings!See our Monthly Practitioner Discounts https://www.mayway.com/monthly-specialsSign up for the Mayway Newsletterhttps://www.mayway.com/newsletter-signupFollow ushttps://www.facebook.com/MaywayHerbs/https://www.instagram.com/maywayherbs/

Join Maria A. Mogollon, MSN, APRN, FNP-BC, a Diabetes and Obesity Nurse Practitioner and former Internal Medicine physician in Venezuela, and Jeff Unger, MD, FAAFP, FACE, DACD, Director, Unger Primary Care Concierge Medical Group, renowned Board-Certified Family Physician, Diabetologist, and co-author of the AACE 2021 Clinical Practice Guideline for the Use of Advanced Technology in the Management of Persons with Diabetes Mellitus, as they delve into crucial topics in diabetes technology. Key topics discussed include the benefits and cost-effectiveness of continuous glucose monitors (CGM) compared to traditional finger-stick methods, practical implementation into practice workflows, interpreting CGM data, and identifying ideal candidates for CGM use. Through case studies and practical examples, they address common concerns and barriers to CGM adoption, providing valuable insights for healthcare professionals on how to have effective conversations with patients and integrate CGM technology into patient care.

DCS 1403: T2D

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

Dr. Laura Jacobsen, a pediatric endocrinologist at the University of Florida joins Ask Dr Jessica for a conversation about Type 1 Diabetes. She explains the differences between type 1 and type 2 diabetes and the symptoms associated with type 1 diabetes. Dr. Jacobsen emphasizes the importance of a balanced diet and regular exercise in diabetes management. She also discusses the screening process for diabetes and the advancements in treatment, particularly the use of continuous glucose monitors (CGMs). This conversation explores various aspects of diabetes treatment and support. It discusses the benefits of real-time information and alarms for low blood sugar, as well as advancements in insulin delivery devices. The conversation also touches on the future of diabetes treatment, including the potential for devices that combine glucose monitoring and insulin delivery. The possibility of a cure for diabetes is explored, along with the need for further advancements in the field. The importance of supporting parents and dispelling myths about diabetes is emphasized. Psychological support for children with diabetes and the value of diabetes camps are also discussed. Dr Jessica Hochman is a board certified pediatrician, mom to three children, and she is very passionate about the health and well being of children. Most of her educational videos are targeted towards general pediatric topics and presented in an easy to understand manner. Do you have a future topic you'd like Dr Jessica Hochman to discuss? Email Dr Jessica Hochman askdrjessicamd@gmail.com. Follow her on Instagram: @AskDrJessicaSubscribe to her YouTube channel! Ask Dr JessicaSubscribe to this podcast: Ask Dr JessicaSubscribe to her mailing list: www.askdrjessicamd.comThe information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditions or formulate treatment plans for specific individuals. If you have a concern about your child's health, be sure to call your child's health care provider.

Commentary by Dr. Valentin Fuster

In this VetFolio Voice podcast episode, Dr. Cassi chats with Dr. Patty Lathan about the pathophysiology of feline diabetes mellitus and some exciting updates in the treatment of diabetes mellitus including sodium-glucose cotransporter 2 (SGLT2) inhibitors. They discuss the importance for veterinary practitioners to understand how these medications work, the recommendations for monitoring these patients and the adverse side effects and complications. They also explore some important updates on insulin, including the availability of glargine at a much lower price and upcoming clinical trials for a once weekly insulin formulation. Want to earn CE from this episode? Be sure to log into VetFolio and take the quiz to qualify for your CE credit! https://www.vetfolio.com/courses/advances-in-the-treatment-of-feline-diabetes-mellitus-podcast-quiz-1

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373 Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize patient outcomes and enhance quality of life. Episode resource links: Hocking, S. L., Markovic, T. P., Lee, C. M. Y., Picone, T. J., Gudorf, K. E., & Colagiuri, S. (2024). Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus. Diabetes care, 47(1), 66–70. https://doi.org/10.2337/dc23-0781   Centers for Disease Control:  Diabetes Care for Providers: https://www.cdc.gov/diabetes/professional-info/index.html   Optifast USA: https://www.optifast.com/   Pattinson, A. L., Seimon, R. V., Harper, C., Nassar, N., Grech, A., Santoso, E. A., Franklin, J., Inan-Eroglu, E., Gibson, A. A., & Sainsbury, A. (2021). Diet Quality following Total Meal Replacement Compared with Food-Based Weight-Loss Diets in Postmenopausal Women with Obesity: A Secondary Analysis of the TEMPO Diet Trial. The Journal of nutrition, 151(11), 3299–3312. https://doi.org/10.1093/jn/nxab311 Guest: Jill M. Terrien, PhD, ANP-BC    Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373 Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize patient outcomes and enhance quality of life. Episode resource links: Hocking, S. L., Markovic, T. P., Lee, C. M. Y., Picone, T. J., Gudorf, K. E., & Colagiuri, S. (2024). Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus. Diabetes care, 47(1), 66–70. https://doi.org/10.2337/dc23-0781   Centers for Disease Control:  Diabetes Care for Providers: https://www.cdc.gov/diabetes/professional-info/index.html   Optifast USA: https://www.optifast.com/   Pattinson, A. L., Seimon, R. V., Harper, C., Nassar, N., Grech, A., Santoso, E. A., Franklin, J., Inan-Eroglu, E., Gibson, A. A., & Sainsbury, A. (2021). Diet Quality following Total Meal Replacement Compared with Food-Based Weight-Loss Diets in Postmenopausal Women with Obesity: A Secondary Analysis of the TEMPO Diet Trial. The Journal of nutrition, 151(11), 3299–3312. https://doi.org/10.1093/jn/nxab311 Guest: Jill M. Terrien, PhD, ANP-BC    Music Credit: Richard Onorato

Have you recently heard about Akkermansia and wondered what it's all about?   We know it's a commensal bacteria that resides in the human gut, thriving in the mucus layer, but its popularity in the wellness world has many asking: Are the benefits truly substantial?   To answer this question let's go over some common claims and what the research actually tells us.   Watch Next… These Probiotics Improve Leaky Gut by 82%: https://www.youtube.com/watch?v=CEt0kdT5AOU&t=239s  NEW Science-Backed Ways to Improve Fatigue, Insomnia, Stress: https://www.youtube.com/watch?v=kEmj83EIfyU&t=8s    Read Next:  Why Probiotic Biodiversity is More Important than Strain: https://drruscio.com/what-is-the-best-probiotic-strain/  The Best Probiotic Protocol? The Triple Therapy Approach: https://drruscio.com/triple-therapy-probiotic-protocol/    Timestamps 00:00  Intro  02:06  What is Akkermansia? 04:29  “Only strain that lives and regulates the gut lining” 05:10  “Major part of the microbiome” 06:49  “Low levels are associated with poor gut health” 07:56  “Good for metabolism & gut health”  10:30  Beware of “Positive Publication Bias” 12:14  Other probiotics that improve gut health 12:54  Increasing Akkermansia naturally 17:49  Key takeaways 18:54  Recommended protocol   Featured Studies  Akkermansia muciniphila: 18 years after its first discovery https://www.frontiersin.org/articles/10.3389/fgstr.2022.1024393/full Akkermansia muciniphila, a human intestinal mucin-degrading bacterium https://pubmed.ncbi.nlm.nih.gov/15388697/ Role of Akkermansia in Human Diseases:  https://pubmed.ncbi.nlm.nih.gov/37111034/ Akkermansia muciniphila improves glucose homeostasis https://pubmed.ncbi.nlm.nih.gov/33820962/ Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans https://pubmed.ncbi.nlm.nih.gov/34223947/ Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression https://pubmed.ncbi.nlm.nih.gov/36835309/ Gut Bifidobacteria Populations in Human Health and Aging https://pubmed.ncbi.nlm.nih.gov/27594848/ Akkermansia muciniphila in the Human GI Tract https://pubmed.ncbi.nlm.nih.gov/30041463/ Intestinal Lactobacillus in health and disease, a driver or just along for the ride? https://pubmed.ncbi.nlm.nih.gov/28866243/ Akkermansia lower in severe obesity https://pubmed.ncbi.nlm.nih.gov/31265324/ Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/34085773/ Akkermansia muciniphila in IBD: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853388/ Mucosa-Associated Microbiota in Patients with IBS https://pubmed.ncbi.nlm.nih.gov/33271532/ Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease https://pubmed.ncbi.nlm.nih.gov/34884399/ Gut microbiome of MS patients https://pubmed.ncbi.nlm.nih.gov/36113426/ Probiotics fortify intestinal barrier function https://pubmed.ncbi.nlm.nih.gov/37168869/ Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in IBS https://pubmed.ncbi.nlm.nih.gov/37686889/ Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in IBD https://pubmed.ncbi.nlm.nih.gov/33555375/ Effects of probiotics on functional constipation https://pubmed.ncbi.nlm.nih.gov/32005532/ Probiotics for Preventing and Treating SIBO https://pubmed.ncbi.nlm.nih.gov/28267052/ Probiotics as an effective therapeutic approach in alleviating depression symptoms https://pubmed.ncbi.nlm.nih.gov/35348020/ Diets that differ in their FODMAP content alter the colonic luminal microenvironment https://pubmed.ncbi.nlm.nih.gov/25016597/ Prebiotic Effect on Gut With Altered FODMAP Intake in Patients with Crohn's Disease https://pubmed.ncbi.nlm.nih.gov/27077959/ Efficacy of a low FODMAP diet in IBS https://pubmed.ncbi.nlm.nih.gov/34376515/ Lipoprotein and Endotoxemia Improvement in Metabolic Syndrome with Gut Microbiota Modification https://pubmed.ncbi.nlm.nih.gov/31451009/ Regulation of gut microbiome by keto diet https://pubmed.ncbi.nlm.nih.gov/36313018/ Islamic fasting leads to an increased Akkermansia https://pubmed.ncbi.nlm.nih.gov/31854308/ Strategies to promote Akkermansia https://pubmed.ncbi.nlm.nih.gov/30416539/ Adjuvant Probiotics Attenuate Glycemic Levels and Inflammatory Cytokines in Type 1 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/35299968/   Get the Latest Updates  Facebook - https://www.facebook.com/DrRusciodc Instagram - https://www.instagram.com/drrusciodc/   DISCLAIMER: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Music featured in this video: "Modern Technology" by Andrew G, https://audiojungle.net/user/andrew_g  *Full transcript available on YouTube by clicking the “Show transcript” button on the bottom right of the video.

Tengo una tía que constantemente dice refranes y de adolescente la escuchaba repetir: la esperanza es lo último que se pierde,  otro muy común aquí en mi país: Dios aprieta pero no ahoga… Mi nombre es Mabel, fui diagnosticada con Diabetes tipo uno a los 47 años de edad, estoy aquí para compartir mi proceso y acompañarte.  Dedico este podcast a todos los latinos que padecen diabetes, especialmente DT1. Tengo oyentes de todas las Américas, si, los latinos en Florida, Texas, California, Virginia; en otros países, me escuchan desde México, Guatemala, Chile, y de Europa, me escuchan desde España. Sin contar otros oyentes más, que se que están, y aun las estadísticas, no me identifican. Y aquí estamos, como latinos apoyándonos.  Estoy agradecida por la vida, por la familia que tengo, por las personas que me aman, por los alimentos sobre mi mesa, por que soy educada, porque trabajo, porque desarrollo mi negocio por mi cuenta.  Aún viven mis padres, mis tres hijos son maravillosos, mi pareja es un gruñón, de gran corazón, empático con mi diagnóstico y acompañante inseparable. Hace como un mes el Times en su versión en español, publicó que los latinos en Texas estaban sufriendo por causa de la diabetes, una ola de amputaciones, personas de todas las edades, pero en su mayoría hombres. Esas noticias me resultan impactantes porque considero que estamos en tiempos modernos, de tanto acceso a la información, y no me cuadra que se padezca de esta manera, por comunidades o grupos étnicos y en los Estados Unidos de América.  Lo que me hace pensar es que estamos en círculos, encerrados y no vemos lo que hay fuera de ellos. Es por eso que el podcast, los libros, y las noticias que educan deben llegar de alguna manera a abrir los horizontes de todo ser humano. Esa es la razón por la que compartir es tan valioso. A mi me compartieron un podcast de emprendimiento, ya luego escucho podcast de 2 o 3 temas distintos que expanden mis pensamientos y me liberan del círculo pequeño que puede representar la comunidad o país donde vivo.      Tener diabetes no es sencillo, tener DT1, lo considero aún más retante. Está fuera de tu control, arreglar el páncreas.  Está bajo tu control, vivir sanamente, según lo consideran sanamente las entidades salubristas más importantes del mundo. Digamos: la Organización Mundial de la Salud conocida como (OMS), o El Consejo de Europa, Programas de Naciones Unidas, etc. Sabes que vivir sanamente es posible, y sabes  que hay referencias para hacerlo en muchas partes de internet, en los periódicos y revistas digitales. Mas nuestra cultura, no nos enseñó a vivir así, en nuestros entornos no reina la aptitud física y mental como protagonistas.  La industria alimentaria no se enfoca en educar, la educación que recibimos no fue orientada al ejercicio físico, ni a una alimentación sana. Al gobierno no le ha importado implementar programas educativos para que desde pequeños, tengamos ese chip, de cultivar orgánico, de comer sano, y de ejercitarnos con frecuencia.  Si sabes que hoy en día, algunos distritos escolares están impulsando el cultivo orgánico, con proyectos para eso, pero todas las generaciones anteriores, carecimos de eso, y además no es aún un requisito en toda el currículo educativo. ¿Por qué no lo hacen? ¿No es acaso la obesidad y diabetes uno de los problemas de salud más grande que enfrentan los países?, especialmente en América.  Mientras tanto, luchas con las coberturas de los planes médicos, el acceso a la insulina para todos y trabajando para vivir bien, mejorar y tener una larga vida, a veces esa lucha te coloca en una situación emocional más frágil. Me pasa que aun teniendo el mejor compromiso no consigo los números que quiero en mi prueba de A1c.  Quiero que sepas que la mejor forma en que  paso el día es cuando hago un desayuno apropiado. Pero como soy de poca variedad para comer, casi siempre me preparo lo mismo. Usé solo la avena como desayuno por mucho tiempo, sin azúcar, con canela y una porción de una taza a taza o un poco más. Si eso me dejaba con hambre, entonces completaba con nueces, o alguna fruta pequeña.  En realidad no tenía grandes picos de glucosa desayunando así, no eran enormes pero sí que los tenía. Pero ya me aburrí, de desayunar lo mismo siempre y además me pasa que si cambio la leche sin lactosa por otra regular, o si en lugar de preparar la avena, la compro en la cafetería…hasta ahí llego con la fortuna de comenzar bien el día. Antes de continuar hago un paréntesis: como escuchas esta es mi experiencia, la que comparto contigo para solidarizarme y que sepas que hay otras personas en la misma situación del dilema, en este caso: de qué comer. Lo que yo llamo alimentos saludables puede que para otra persona no lo sean, no soy médico, ni nutricionista. Leo y luego adapto a mi rutina, pruebo si me resulta y lo comparto contigo. Si quieres una lista de alimentos aprobados, debes visitar a un nutricionista o nutriólogo como le llaman en algunos países, para una recomendación personal y clínica. Seguimos! Ahora me resulta más fácil combinar proteína y cereal. Ya sé que tengo que eliminar el cereal, aunque sea de avena. Pero un huevo hervido, y luego la taza de cereal, frío o caliente me está resultando. Y lo que pasa es que veo el desayuno “ideal”, lo reconozco, pero no me apetece.  No me apetece desayunar tostadas integrales con aguacate, ni omelette con espinacas, ni verduras, hasta ahora. Bueno, en fin, si desayuno proteína, el día transcurre mejor para mi, y, quizás ya lo estás haciendo tu. Cuéntame qué desayunas?   Solo si tienes diabetes y te monitoreas constantemente, podrás descartar lo que te vuela la glucosa a niveles del más allá. Ir adaptando los alimentos que te mantienen estable y cuidar de Ti, de la mejor manera posible. Entonces qué?, pues pensando en voz alta, habrá que añadir algunos vegetales al desayuno. ¿Qué te parece? Reflexiono hoy aquí contigo y consciente de que no había querido incursionar con las verduras en la mañana, debo dar el paso, al parecer ya es tiempo. Antes ni miraba el aguacate, hoy día puedo probarlo en pequeñas porciones. ¿Te ha pasado a ti con algún alimento saludable? ¿La leche de soja por ejemplo? Recuerda que tengo la cuenta en IG https://www.instagram.com/hola.vidaenpositivo donde puedes escribirme por mensaje directo. Me encantará leer cómo lo llevas tú. Y de una vez, comparte la pagina, comparte el podcast, coloca tu valoración de 5 estrellas en la plataforma donde me escuchas el podcast, para llegar a otras personas, especialmente hispanos con diabetes. Me ha encantado compartir contigo, desde donde quiera que me escuchas parece que estamos cerca, si! Estoy en el Caribe, en la isla de Puerto Rico y de aquí para el mundo sin perder la esperanza, contigo nos vamos por encima del diagnóstico, !Claro que si! Usé como referencia un articulo de: El Times en Español

Quem assina o Medcof pelo link do TdC ganha meses gratuitos do Guia TdC! Extensivo Elite: Ganhe 12 meses de Guia TdC Extensivo Regular: Ganhe 6 meses de Guia TdC Extensivo para R+ de Clínica Médica: https://extensivo.grupomedcof.com.br/extensivo-2024-r-clinica-medica-tdc Extensivo para R1: https://extensivo.grupomedcof.com.br/extensivo-r1-tdc Parceria TdC + Medcof! Comece a estudar antes dos seus concorrentes e seja aprovado na residência médica que você quiser! Na Medcof, você estuda para residência médica com - inteligencia artificial generativa (o único que tem isso): permite gerar questões de qualquer tema ou encontrar sua dúvida pesquisada no minuto e segundo exato da aula que o professor está falando a respeito, economizando tempo de busca. - time de especialistas e preceptores dos grandes serviços - USP, unifesp, einstein, unicamp - Aulas curtas mas completas, que abordam do básico ao avançado tudo o que pode cair na prova, com boa didática. Dividimos as aulas em verde, amarelo e vermelho, de acordo com o nível de prioridade. - Questões transformadoras (com comentários feitos pelos especialistas de cada especialidade, que revisam o tema da questão e não apenas explicam as alternativas); - Flashcards digitais com revisão espaçada, cofcards físicos (3000 flashcards físicos); - Fichas resumo físicas (e digitais) que resumem cada aula. - simulados mensais comentados por especialistas e com ranking, para analisar como você está perante os outros alunos. - Tarefas mínimas semanais (mesmo naquela semana que está uma correria, separamos o mínimo de questões obrigatórias de serem feitas naquela semana). - Raio-x da banca das principais provas do Brasil (uma revisão de véspera do que caiu nos anos anteriores, dado pelo especialista). Joanne, Marcela e Nathalie discutem sobre o acompanhamento do paciente com diabetes mellitus tipo 2. São abordadas, metas de tratamento, avaliação de lesão de órgão alvo e cuidado multidisciplinar. Referências em breve.

Management of the diabetic patient can be a delicate balance of watching the numbers and considering the patient attached to the numbers. Evaluating factors like body weight, appetite and water consumption in conjunction with monitoring blood glucose is the key to effectively managing diabetic patients and avoiding overmanagement. In this episode of VetFolio Voice, Dr. Cassi chats with Dr. Nyssa Reine-Salz about the nuances of managing diabetic patients and considerations for patients who do not regulate as expected.

Resources and ResearchMolly Kellogg Free Tips: https://mollykellogg.com/counseling-tips/ The Four Processes in MI: https://mollykellogg.com/tip-114-the-four-processes-in-motivational-interviewing/MINT: https://motivationalinterviewing.org/understanding-motivational-interviewing Psychology Today: https://www.psychologytoday.com/us/blog/soul-console/202307/compassion-is-more-than-niceness[1] Kazemi J, Rahmati F. Comparing the effectiveness of motivational interviewing and self-development education on type II diabetes mellitus patients' lifestyle. J Educ Health Promot. 2021;10:434. Published 2021 Nov 30. doi:10.4103/jehp.jehp_860_20 [2] Steffen PLS, Mendonça CS, Meyer E, Faustino-Silva DD. Motivational Interviewing in the Management of Type 2 Diabetes Mellitus and Arterial Hypertension in Primary Health Care: An RCT. Am J Prev Med. 2021;60(5):e203-e212. doi:10.1016/j.amepre.2020.12.015 [3] Hardcastle, S.J., Taylor, A.H., Bailey, M.P. et al. Effectiveness of a motivational interviewing intervention on weight loss, physical activity and cardiovascular disease risk factors: a randomised controlled trial with a 12-month post-intervention follow-up. Int J Behav Nutr Phys Act 10, 40 (2013). https://doi.org/10.1186/1479-5868-10-40

¡Hola! En el episodio del podcast de hoy os explico todo lo relacionado con la diabetes mellitus gestacional (DMG). Entre las dudas que os resuelvo están:En qué se diferencia la DMG de la diabetes tipo 1 y 2Qué mujeres tienen más riesgo de desarrollar DMG¿Si tienes una insulina y glucosa preconcepción normal, es un seguro para no desarrollar DMG?¿Por qué se realiza la curva de glucosa “corta” y la “larga” para diagnosticar la DMG a diferencia de en los otros casos de diabetes?¿Si no estas acostumbrada a comer azúcar, no es perjudicial este “chute de azúcar”?¿Puede afectar al bebe la toma de 50/100 g de azúcar de la prueba de sobrecarga de glucosaPor qué es clave que NO modifiques tu dieta los días previos a la prueba de sobrecarga de glucosa¿Se puede diagnosticar DMG con un glucómetro en vez de la sobrecarga de glucosa?¿Qué suplementos se pueden tomar para reducir el riesgo de diabetes mellitus gestacional o si la han diagnosticado?¿Aumenta el riesgo de DMG ser sometida a tratamientos de FIV?¿Puedes tener más riesgo de desarrollar diabetes tras el embarazo?Como os he dicho, los suplementos a los que hago referencia o bien son los de mi marca https://ivbwellness.com o sino, son los que yo os selecciono cuidadosamente y guardo en mis stories destacados de “favoritos” en mi Instagram @isabelvina ¡Espero que os guste, acordaos de suscribiros y valorar mi trabajo en el podcast así me consigo llegar a más gente! Cualquier duda extra, mira mi INSTAGRAM @isabelvina Allí tengo muchas más dudas de hormonas y metabolismo resueltas!Además, tenéis mi web https://ivbwellness.com para consultas y para poder adquirir mi línea de suplementos de alta calidad destinados a trabajar con tu cuerpo y sistema hormonal de manera natural para devolverte la calidad de vida y bienestar que mereces. ¡Nos oímos en 2 sábados!

Commentary by Dr. Valentin Fuster

Full Episode HERE Your 14-Day Jump-Start For Nursing School Success Begins Now!!! Come along for a 14-day series that will push you ahead of the curve, helping you break through the most difficult nursing content with a FREE 10-minute video each day. You can access these lesson videos completely free of charge! Simply set up a password, and you're good to go. Diabetes mellitus, or diabetes, is a chronic condition affecting how your body handles sugar (glucose). It's due to issues with insulin, a hormone that regulates sugar levels. There are 2 types of diabetes mellitus: Type 1 Diabetes: The immune system attacks insulin-producing cells. Type 2 Diabetes: The body struggles with insulin use and production. Let's dive in a bit further and go over everything thing you need to know about Diabetes Mellitus so you can take the best care of your patients! Full Episode HERE

Join Yvonne Brandenburg, RVT, VTS SAIM and Jordan Porter RVT, VTS SAIM as we talk about: We delve into the importance of nutritional management in pets with diabetes mellitus. We explore the definition of the disease, discuss dietary considerations for dogs and cats, share client communication tips, and highlight important cautions to keep in mind for the well-being of your furry friends.    Resources We Mentioned in the Show   "Nutrition and Diabetes Mellitus." Today's Veterinary Practice. Retrieved from: https://todaysveterinarypractice.com/nutrition/nutrition-and-diabetes-mellitus/#:~:text=What%20Food%20Should%20I%20Recommend,the%20dog%20insulin%20twice%20daily. "Diabetes Mellitus." UC Davis School of Veterinary Medicine. Retrieved from: https://www.vetmed.ucdavis.edu/hospital/animal-health-topics/diabetes-mellitus "Diabetes Mellitus." Veterinary Information Network (VIN). Retrieved from: https://www.vin.com/apputil/content/defaultadv1.aspx?id=7054864&pid=12886 "Diets for Diabetic Dogs." Cornell University College of Veterinary Medicine - Riney Canine Health Center. Retrieved from: https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/diets-diabetic-dogs "Nutrition for Dogs with Diabetes." Merck Animal Health. Retrieved from: https://www.merck-animal-health-usa.com/vetsulin/dogs/nutrition-for-dogs-with-diabetes     Thanks so much for tuning in. Join us again next week for another episode!  Want to earn some RACE approved CE credits for listening to the podcast? You can earn between 0.5-1.0  hour of RACE approved CE credit for each podcast episode you listen to.    Join the Internal Medicine For Vet Techs Membership to earn and keep track of your continuing education hours as you get your learn on!   Join now! http://internalmedicineforvettechsmembership.com/   Get Access to the Membership Site for your RACE approved CE certificates Sign up at https://internalmedicineforvettechsmembership.com  Get Access to the Technician Treasure Trove  Sign up at https://imfpp.org/treasuretrove    Thanks for listening!  – Yvonne and Jordan     

In this VETgirl podcast, we talk to Dr. Andrew Bugbee, DACVIM about diabetes mellitus in your feline patients, and what you need to know. Find out what some of the challenges are when it comes to discussing diabetes with cat owners, and what matters most to cat owners when they get the diagnosis of diabetes mellitus? After all, what's so hard about managing diabetes in cats? Learn about Bexacat, and how it may change the way we treat this disease, compared to how we treat with insulin. What's the "right" patient for Bexacat, and how do we monitor cats on SGLT2 inhibitors like Bexacat? Learn what's new in feline diabetes mellitus with this VETgirl podcast! Today's VETgirl podcast is sponsored by Elanco. A global animal health leader, we rigorously innovate to improve the health of animals, benefit our customers, support our causes and strengthen our communities. We are excited about bringing new solutions to pet owners, veterinarians and the animals we all love. Our latest innovation in the diabetes mellitus arena promises to change the way we think about treating this disease in cats forever. Indication: Bexacat is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. Important Safety Information: Before using this product, it is important to read the entire product insert, including the boxed warning. See package insert for full prescribing information. Cats treated with Bexacat may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death. Development of these conditions should be treated promptly, including insulin administration and discontinuation of Bexacat. Do not use Bexacat in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of Bexacat in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of Bexacat, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death. Sudden onset of hyporexia/anorexia, lethargy, dehydration, diarrhea that is unresponsive to conventional therapy, or weight loss in cats receiving Bexacat should prompt immediate discontinuation of Bexacat and assessment for diabetic ketoacidosis, regardless of blood glucose level. Bexacat should not be initiated in cats with pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis. Due to risk of severe adverse reactions, do not use Bexacat in cats with evidence of hepatic disease or reduced renal function. Consult a physician in case of accidental ingestion by humans. Bexacat is a trademark of Elanco or its affiliates. PM-US-23-0825

SCAI consensus document on LAAC, semaglutide/tirzepatide disruption, NSAIDs, and interventional echocardiography are the topics discussed by John Mandrola, MD, on this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. SCAI Consensus Document New Update on Left Atrial Appendage Closure Recommendations https://www.medscape.com/viewarticle/990507 - SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure https://doi.org/10.1016/j.jscai.2022.100577 - Transcatheter Left Atrial Appendage Closure Comes of Age https://doi.org/10.1016/j.jscai.2023.100592 - EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update https://doi.org/10.1093/europace/euz258 II. Semaglutide and Tirzepatide Disruption Tirzepatide Powers 'Unprecedented' Weight Loss in Obesity Trial https://www.medscape.com/viewarticle/975061 - Obesity Management in Primary Care https://reference.medscape.com/recap/982874 - The $76 Billion Diet Industry Asks: What to Do About Ozempic? https://www.wsj.com/amp/articles/ozempic-wegovy-mounjaro-weight-loss-industry-89419ecb III. NSAIDs and HF NSAID Use in Diabetes May Worsen Risk for First HF Hospitalization https://www.medscape.com/viewarticle/990642 - Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus https://doi.org/10.1016/j.jacc.2023.02.027 IV. Interventional Echocardiography New ASE Guideline on Interventional Echocardiography Training https://www.medscape.com/viewarticle/990520 - Recommendations for Special Competency in Echocardiographic Guidance of Structural Heart Disease Interventions: From the American Society of Echocardiography https://doi.org/10.1016/j.echo.2023.01.014 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact: news@medscape.net